FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

West-Ward Pharmaceuticals Dexamethasone Sodium Phosphate Injection Recall

Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 06…

West-Ward Pharmaceuticals Corp. · Eatontown, NJ

Risk level
Class III
Reported by FDA
Nov 29, 2017
Recall ID
D-0094-2018
Check your lot numberHow we source this data

Summary

West-Ward Pharmaceuticals recalled Dexamethasone Sodium Phosphate Injection starting Nov 6, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0094-2018 on Nov 29, 2017. Reason: Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound). Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).

Product description

Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packaged in 25 x 5 mL Vials per shelf pack (NDC 0641-6146-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.

Lot numbers, UPCs & expiration codes

Lot #: 106352, Exp 10/18

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0094-2018
Classification
Class III
Status
Terminated
Recall initiated
Nov 6, 2017
FDA report date
Nov 29, 2017
Quantity
1,896 shelf packs
Recall type
Voluntary: Firm initiated
Recalling firm
West-Ward Pharmaceuticals Corp.

Original FDA data

Every field from FDA enforcement report D-0094-2018, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
78415
Address
401 Industrial Way West
Code information
Lot #: 106352, Exp 10/18
Postal code
07724-2209
Report date
Nov 29, 2017
Product type
Drugs
Recall number
D-0094-2018
Classification
Class III
Recalling firm
West-Ward Pharmaceuticals Corp.
Product quantity
1,896 shelf packs
Termination date
Apr 1, 2020
Reason for recall
Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packaged in 25 x 5 mL Vials per shelf pack (NDC 0641-6146-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Nov 6, 2017
Initial firm notification
Letter
Center classification date
Nov 22, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0094-2018, published Nov 29, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls